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inferior epigastric perforator (DIEP), and superficial inferior epigastric artery (SIEA) flaps.
From its description in 1982 through 2012, the pedicled TRAM flap was the most frequently performed abdominally based flap. 2 In 2012, DIEP flaps surpassed TRAM flaps in popularity, according to statistics published by the American Society of Plastic Surgeons. 3 Consistent with these statistics, the Nationwide Inpatient Sample Database demonstrated a decrease in the number of pedicled and free TRAM flaps between 2009 and 2011, whereby DIEP flaps increased over the same period. 4 Interpretation of prior studies comparing outcomes of the available abdominal flap reconstruction modalities have been limited by their retrospective designs, lack of controls for potential confounding variables, omission of patientreported outcome measures, and single-center patient populations. Head-to-head comparisons of the procedures are lacking, and many published studies have shown contradictory results.
Our study was designed to compare surgical complications and patient-reported outcomes among the most common abdominally based autologous breast reconstruction modalities using data from the Mastectomy Reconstruction Outcomes Consortium Study. The Mastectomy Reconstruction Outcomes Consortium Study is a prospective, multicenter, cohort study comparing outcomes of various common breast reconstruction procedures. It presents a unique opportunity to address these questions, as patients were enrolled at 11 different sites, and all abdominally based procedures were performed, including pedicled and free TRAM, DIEP, and SIEA flaps. Our study aims were as follows: (1) to assess abdominal donor-site and breast complications, and (2) to compare patientreported outcomes for these abdominally based flap breast reconstruction procedures.
PATIENTS AND METHODS

Study Population
Patients were recruited from the Mastectomy Reconstruction Outcomes Consortium, a 5-year, prospective, multicenter cohort study of mastectomy reconstruction patients funded by the National Cancer Institute. Women 18 years or older undergoing first-time, unilateral or bilateral mastectomy breast reconstruction were eligible for participation. Fifty-seven plastic surgeons from 11 centers in the United States (i.e., Michigan, New York, Illinois, Ohio, Massachusetts, Washington, D.C., Georgia, and Texas) and Canada (i.e., British Columbia and Manitoba) contributed patients to the study, which began enrollment in February of 2012.
Appropriate institutional review board or research ethics board approval was obtained from all participating sites. For the purpose of this analysis, we included patients who underwent first-time immediate or delayed reconstruction after mastectomy with one of the following types of breast reconstruction: pedicled or free TRAM (including muscle-sparing free TRAM), DIEP, or SIEA flap. All patients had a minimum of 1-year follow-up after reconstruction. Patients undergoing prophylactic and therapeutic mastectomies were included, as were both unilateral and bilateral reconstructions. Exclusion criteria consisted of patients who had less than 1-year follow-up, bilateral cases with mixed reconstruction types (e.g., implant and autologous), or mixed timing of reconstruction (e.g., immediate on one side and delayed on the other).
Data Collection
Demographic and clinical characteristics of patients were collected, including age, body mass index, laterality (i.e., unilateral versus bilateral), indication for mastectomy (i.e., therapeutic versus prophylactic), mastectomy type (i.e., nipple-sparing versus skin-sparing), timing of reconstruction (i.e., immediate versus delayed), smoking status (i.e., nonsmoker, previous smoker, or current smoker), radiation therapy (i.e., none, before mastectomy, after mastectomy, or after reconstruction), and adjuvant chemotherapy. Patients were also asked to report whether they had diabetes regardless of insulin dependence.
Complications were collected by trained study staff at 1 year and 2 years postoperatively through review of electronic medical records. A training manual, including study protocols and answers to questions about clinical data, was developed before study implementation. Using this manual, the study manager conducted initial in-person training with each coordinator and monthly conference calls with all coordinators to ensure consistency. In addition, the study manager performed yearly on-site data audits of clinical data and ongoing database querying for data consistency.
For the purpose of this study, cumulative 2-year complication data were analyzed. Abdominal donor-site complications included hematoma, wound dehiscence, wound infection, donor-site necrosis, chronic fat necrosis, seroma, abdominal wall bulge/laxity/hernia, and hypertrophic or keloid scarring. Breast complications included hematoma, wound dehiscence, wound infection, mastectomy skin flap necrosis, partial or total flap loss, chronic fat necrosis, seroma, and hypertrophic or keloid scarring.
Patient-reported outcomes were measured using the breast reconstruction modules of the BREAST-Q and the Patient-Reported Outcomes Measurement Information System survey instruments. Both instruments have been previously validated. 5, 6 The BREAST-Q breast reconstruction module specifically measures patient satisfaction with breast, psychosocial well-being, physical well-being of chest and abdomen, and sexual wellbeing. Answers to questions in the BREAST-Q are allotted point values, and then the scores for different questions are added together. The summed score is then converted to a scale that ranges from 0 to 100. 7 This process of quantifying responses was performed using the Q-Score software. A higher BREAST-Q score reflects higher patient satisfaction or health-related quality of life. The PatientReported Outcomes Measurement Information System was used to assess both physical function and pain level. Both BREAST-Q and the PatientReported Outcomes Measurement Information System questionnaires were administered to patients preoperatively to measure baseline scores, and then postoperatively at years 1 and 2. Patients had the option of completing the questionnaires online or in paper format. Only patients who successfully completed reconstruction were included for patient-reported outcome analysis.
Statistical Analysis
Patient characteristics by four procedure groups (pedicled TRAM, free TRAM, DIEP, and SIEA flaps) were analyzed using one-way analysis of variance or chi-square tests. Cumulative 2-year postoperative complication rates and both 1-and 2-year patient-reported outcomes were summarized by procedure type.
Multivariable adjustments were performed using mixed-effects regression models to further compare the outcomes of patients across procedure types. For each model, we included three of the four procedure types as the primary predictor variables, with DIEP as the reference group. Contrasts of coefficients were performed to obtain other pairwise comparisons between procedures. Each model also controlled for relevant clinical characteristics and baseline patient-reported outcome scores (for patient-reported outcome models), and included random intercepts for centers (hospitals) to account for between-center variability. Baseline and postoperative patient-reported outcomes and certain covariates were missing for some patients. To account for such missing data, multiple imputations with chained equations were used to create 10 complete imputed data sets, each of which was used to run the regression models specified above. The results were then combined using Rubin's rules. 8 Statistical analysis was performed using SAS 9.4 (SAS Institute, Inc., Cary, N.C.), and statistical significance was set at 0.05.
RESULTS
Patient Characteristics
A total of 720 patients had 
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Donor-Site Complications at 2 Years after Reconstruction
The overall donor-site complication rate was 27.3 percent at 2 years postoperatively. Pedicled TRAM and free TRAM flaps had lower rates of any donor-site complication (pedicled TRAM flap, 18 percent; free TRAM flap, 15.2 percent) compared with DIEP (27.9 percent) and SIEA (53.2 percent) flaps. The SIEA flap group had the highest rate of seroma (30.7 percent), wound dehiscence (27.4 percent), and wound infection (14.5 percent). The abdominal wall bulge/laxity/hernia rate was higher in the pedicled TRAM flap group (9 percent) and in the free TRAM flap group (5.4 percent) compared with the DIEP and SIEA flap groups. The descriptive donor-site complication results are summarized in Table 2 .
Multivariable analysis showed that SIEA flaps were associated with significantly higher rates of abdominal donor-site complications (OR, 2.73; p = 0.001) compared with DIEP flaps (Table 3) . Although not statistically significant, the odds of donor-site complications were lower in free TRAM (OR, 0.52; p = 0.06) and pedicled TRAM (OR, 0.63; p = 0.18) flap recipients than in DIEP flap recipients, and were significantly lower in free TRAM (OR, 0.23; p < 0.001) and pedicled TRAM (OR, 0.19; p < 0.001) flap recipients than in SIEA flap recipients, even after adjusting for covariates. Previous and current smoking and diabetes were associated with significantly higher odds of abdominal donor-site complications. Age, body mass index, laterality, timing of reconstruction, radiation therapy, and adjuvant chemotherapy did not have significant effects on donor-site complications.
Breast Complications at 2 Years after Reconstruction
The overall 2-year breast complication rate was 29.6 percent. Free TRAM flaps had lower rates of any breast complication (19.6 percent), compared with other abdominal flap types (i.e., pedicled TRAM flaps, 32.1 percent; DIEP flaps, 31 percent; and SIEA flaps, 33.9 percent). Table 2 summarizes the descriptive breast complication results.
Multivariable analyses for breast complications revealed no significant differences in the rates of overall breast complications among the abdominal flap procedures. Higher body mass index and active smoking were associated with significantly greater odds of any breast complication. Age, laterality, prophylactic versus therapeutic indication, delayed reconstruction, diabetes, radiation therapy, and adjuvant chemotherapy were found to be nonsignificant factors for breast complications. Table 3 presents the results of the mixed-effects logistic regression analysis for 2-year postoperative breast complications. 
Patient-Reported Outcome Measures
The patient-reported outcome measure scores assessed using the BREAST-Q and the Patient-Reported Outcomes Measurement Information System survey instruments are summarized in Table 4 . Before reconstruction, patients across the four procedure groups reported similar patient-reported outcome scores. Multivariable analysis (Table 5) showed SIEA flaps to be associated with higher abdominal physical well-being scores compared with DIEP flaps at 1 year postoperatively by 4.72 (p = 0.05). Interestingly, however, this difference was no longer seen at 2 years postoperatively (0.58; p = 0.83). One year after reconstruction, the free TRAM and pedicled TRAM flaps showed a trend toward lower means compared with DIEP flaps by 4.16 (p = 0.05) and by 4.01 (p = 0.08), respectively (Table 5 ). Free and pedicled TRAM flaps showed significantly lower means compared with SIEA flaps by 8.88 . Age, body mass index, prophylactic indication, timing of reconstruction, diabetes, radiation therapy, and adjuvant chemotherapy were not significant variables in abdominal well-being. In contrast to the abdomen-specific patientreported outcome results, multivariable analysis of the BREAST-Q patient-reported outcome scales unrelated to the abdominal donor site for the most part demonstrated no significant differences between the reconstruction procedure groups compared at both 1 and 2 years postoperatively (Table 5 ). However, the pedicled TRAM flap group reported significantly lower physical well-being of chest scores at 2 years postoperatively by 3.92 (p = 0.040) compared with the DIEP flap group. There were no significant differences in physical function or pain scores across pedicled TRAM, free TRAM, DIEP, or SIEA flaps as measured by the Patient-Reported Outcomes Measurement Information System survey instrument (Table 5) .
DISCUSSION
The abdomen remains the most commonly used donor site for autologous breast reconstruction. Our current study uses data from the Mastectomy Reconstruction Outcomes Consortium, the largest prospective multicenter database available, to compare the four most commonly performed abdominally based flap breast reconstructions: pedicled TRAM, free TRAM, DIEP, and SIEA flaps.
Patient Characteristics
We found some significant differences in the baseline clinical characteristics of patients in the different procedure groups. The differences in age and body mass index, although statistically significant, are not that clinically significant. The higher proportion of unilateral reconstructions in patients undergoing pedicled TRAM flap and bilateral reconstruction in patients undergoing DIEP flaps likely reflects surgeon preferences to minimize muscle harvest based on the number of sides to be reconstructed. SIEA flaps were performed more commonly in an immediate setting and were more likely to be irradiated after reconstruction. Most importantly, all of these differences were controlled for in the multivariable analysis.
Complications
The rate of complications after SIEA flaps was higher in our study compared to earlier benchmarks in the literature, with an overall abdominal complication rate of 53.2 percent at 2 years. This appeared to be secondary to the high rate of seroma after SIEA flaps, which was prospectively found to be approximately 30 percent. Our relatively high SIEA abdominal complication rates surpass the complication rates reported by prior studies. Chevray reported on his early experience with SIEA flaps from consecutive patients undergoing abdominally based free flap breast reconstruction between 2001 and 2002 and reported no seromas. *Denotes the mean difference in patient-reported outcome between the corresponding procedure type and DIEP flaps (reference category), based on separate mixed-effects regression model for each patient-reported outcome outcome. Each model included as covariates baseline outcome, age, body mass index, laterality, indication for mastectomy, timing of reconstruction, smoking status, diabetes, radiation therapy, and chemotherapy. Each model also included random intercepts for centers (hospitals) to account for between-center variability. The results were combined based on 10 multiply imputed data sets.
Plastic and Reconstructive Surgery • February 2018 seroma. 10, 11 Reports of SIEA flaps are limited in the literature because these procedures are performed less commonly and most studies have focused on either hernia/bulge rates or microvascular complications. [10] [11] [12] [13] Our relatively high rate of SIEA flap donor-site complications may reflect the more rigorous and systematic prospective data collection methods used in our study and its ability to capture more complete complication data. Technical factors may also have contributed to our findings, including the extent of dissection along the superficial inferior epigastric pedicle, the number and location of drains placed, the use of quilting sutures, and the provision of a binder postoperatively to the patient.
When reviewing the breast-related complication rates, no significant differences were noted among the abdominal flap modalities compared. The free TRAM flap group showed a trend toward a significantly lower breast complication rate compared with the DIEP flap group. However, our study results suggest that the type of abdominally based flap reconstruction does not have a significant impact on the overall breast complications. This finding is consistent with the results of Zhong et al., 14 who used propensity score analysis to compare muscle-sparing free TRAM flaps with DIEP flaps and found that flap type did not affect the rate of breast complications.
Patient-Reported Outcomes
Our study demonstrated some significant differences in patient-reported outcomes among the various abdominal flap breast reconstruction options when abdominal strength and symptoms were assessed using the abdomen-specific BREAST-Q scale. This scale focuses on evaluation of symptoms such as difficulty sitting up or performing everyday activities because of abdominal muscle weakness. Although it may not have been surprising that the SIEA flap demonstrated superior abdomen-specific BREAST-Q scores at 1 year, it was interesting to note that this difference was no longer seen at 2 years postoperatively. Pedicled and free TRAM flaps showed lower abdomenspecific BREAST-Q scores compared with DIEP flaps at year 1, then demonstrated significantly lower scores compared with DIEP flaps at 2 years, with an even greater difference. The higher patient-reported abdominal outcomes for DIEP compared with pedicled and free TRAM flaps remained even after controlling for laterality. This finding is consistent with the results published by Macadam et al. in 2016 that showed higher BREAST-Q Physical Well-being Abdomen scores in their retrospective series of DIEP flaps compared with pedicled TRAM flaps. 15 Such results seem to indicate that patients' abdominal donor-site physical well-being continues to evolve over the longterm and further substantiate the importance of continued follow-up and evaluation, likely even beyond 2 years postoperatively. That being said, bilateral reconstruction showed the most significant negative impact on abdominal physical wellbeing (−7.57; p < 0.001), and DIEP flap surgery likely plays a more significant role in the setting of bilateral breast reconstruction. Future studies with longer follow-up and larger sample size are needed to determine the difference in patientreported outcomes after the different abdominally based reconstructions based on laterality.
One limitation in our patient-reported outcome assessment using BREAST-Q scores is that the clinical meaning of BREAST-Q scores and the smallest clinically relevant differences in scores are not yet defined. Research in this area is ongoing, and although interpretative data on an individual patient's score in abdominal physical well-being is unknown at this time, a four-point decrease in this scale appears to be moderately significant. As these instruments become more widely used, the clinical meaning of BREAST-Q scores will undoubtedly be better defined and understood.
Our abdominal hernia/bulge rate was noted to be higher in pedicled and free TRAM flap groups based on our descriptive data, and this finding is similar to other published studies suggesting lower abdominal hernia rates following DIEP flaps compared with pedicled TRAM flaps. [16] [17] [18] However, interpretation of our current data in this regard is limited by the small sample size of any specific abdominal donor-site complication among the abdominal flap reconstruction types and relatively short follow-up. Prior studies have shown variable hernia/bulge rates following pedicled TRAM flaps 15, 16, 19 and an apparent increase in the reported rate when patients were followed for as long as 64 months postoperatively. 20 Although the large number of plastic surgeons involved in our multicenter study may provide a more accurate "real-world" measure of complications and quality of life compared with the retrospective single-surgeon series that predominate in the clinical literature, it may also constitute an inherent limitation of our analysis because of a lack of standardization in techniques, such as the abdominal donor-site closure. Factors including mesh placement versus primary fascial closure, the method of mesh inset, and drain locations may affect the rate of donor-site complications. Prior studies have shown that after primary fascial closure for unilateral free flap breast reconstruction, bulge/hernia rates are significantly higher for free TRAM flaps (11.8 percent) compared with DIEP flaps and muscle-sparing free TRAM flaps (4 to 5 percent), but use of mesh successfully reduced the bulge/ hernia rate by 70 percent with no subsequent difference in bulge/hernia rates among the three flap groups. 20 Our results are also limited by the fact that patients who underwent muscle-sparing free TRAM flaps were included in the free TRAM flap group. The degree of muscle or fascia sparing in the free TRAM flap group was not specified on a case-by-case basis, and this lack of differentiation could have enhanced the free TRAM results. In addition, prior abdominal surgery could have impacted the abdominal hernia/bulge complication rate (9 percent), but these data were not available for our current analysis. Future prospectively designed studies would be valuable specifically comparing long-term abdominal donor-site outcomes following different donor-site closure techniques and degrees of muscle-sparing among TRAM flap techniques.
Although no procedure effect was seen in the patient-reported outcomes measured by the Patient-Reported Outcomes Measurement Information System survey, this may reflect the more generic nature of the Patient-Reported Outcomes Measurement Information System survey instrument and its limitation in assessment of more specific physical function such as abdominal well-being. Nonetheless, bilateral breast reconstruction and higher body mass index were consistently associated with significantly lower physical function scores at both 1 and 2 years postoperatively. These findings highlight the importance of considering other clinical factors, such as obesity and bilateral breast reconstruction, in addition to the reconstruction procedure type, as risk factors for poor long-term physical function. For instance, the decision to commit to prophylactic bilateral mastectomies with abdominal flap reconstruction should be made with caution. Similarly, women with unilateral breast cancers who desire a contralateral prophylactic mastectomy and bilateral autologous reconstruction should be made aware of the anticipated negative impact that this decision will have on their abdominal wellbeing (in comparison with unilateral autologous reconstruction).
When reviewing the breast-related patient satisfaction scores, general patient and clinical factors seem to play a more significant role than the specific abdominal flap procedure type. No • Some payers may disallow code 49568 and require use of the unlisted procedure code, 49999. When reporting code 49999, crosswalk the code with code 49568 for the payer to determine reimbursement.
• All breast reconstruction procedures should be preauthorized with the payer prior to surgery. Disclosure: Dr. Janevicius is the president of JCC, a firm specializing in coding consulting services for surgeons, government agencies, attorneys, and other entities. significant difference in breast-related patientreported outcomes was noted among the abdominal flap modalities compared after controlling for other covariates. Those covariates that were found to be significant factors for breast-related patient-reported outcome outcomes, such as obesity, radiotherapy, and age, have been addressed in other Mastectomy Reconstruction Outcomes Consortium-based publications.
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CONCLUSIONS
Although all abdominally based flaps are viable options for breast reconstruction, patient counseling should highlight data-driven differences in complication rates and patient-reported outcomes. Care should be taken with the abdominal donor site for SIEA flaps, where the high rate of complications such as seroma and dehiscence can diminish the positive effect of abdominal donorsite strength preservation on long-term patientreported outcomes. Pedicled and free TRAM flap patients have lower abdominal physical well-being compared with DIEP flap and SIEA flap patients. Our current study results suggest that 2-year followup may not be sufficient when trying to evaluate true outcomes of abdominal flap reconstructions, and ongoing longer term follow-up is necessary to determine the ultimate impact in terms of physical function and patient satisfaction. 
